This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Analysis of Biomarkers in Patients With Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation Treated With Menin Inhibition. | MicrobiomeTrials
← Back to trials NCT07627568
Analysis of Biomarkers in Patients With Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation Treated With Menin Inhibition. Recruiting OBSERVATIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-05-30Est. Completion: 2027-05-30
Enrollment target: 20 participantsLocations University of Freiburg Mdical Center, Freiburg im Breisgau, Germany Other microbiome trials you might be interested in Inherited Hematological Diseases Rare Diseases FPDMM
Background:
Genes tell the body and its cells how to work. Familial platelet disease (FPD) or FPD with associated malig…
Bethesda, United States Est. completion Dec 31, 2028
Acute Myeloid Leukemia Relapse/Recurrence
This is a multicenter, randomized, open-label, pragmatic low intervention clinical trial comparing high intensity reindu…
Brno, Czechia Est. completion Jan 2028